Literature DB >> 27875293

Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition.

Himakarnika Alluri1, Marcene Grimsley2, Chinchusha Anasooya Shaji1, Kevin Paul Varghese3, Shenyuan L Zhang4, Chander Peddaboina1, Bobby Robinson1, Madhava R Beeram5, Jason H Huang6, Binu Tharakan7,5.   

Abstract

Blood-brain barrier (BBB) breakdown and the associated microvascular hyperpermeability followed by brain edema are hallmark features of several brain pathologies, including traumatic brain injuries (TBI). Recent studies indicate that pro-inflammatory cytokine interleukin-1β (IL-1β) that is up-regulated following traumatic injuries also promotes BBB dysfunction and hyperpermeability, but the underlying mechanisms are not clearly known. The objective of this study was to determine the role of calpains in mediating BBB dysfunction and hyperpermeability and to test the effect of calpain inhibition on the BBB following traumatic insults to the brain. In these studies, rat brain microvascular endothelial cell monolayers exposed to calpain inhibitors (calpain inhibitor III and calpastatin) or transfected with calpain-1 siRNA demonstrated attenuation of IL-1β-induced monolayer hyperpermeability. Calpain inhibition led to protection against IL-1β-induced loss of zonula occludens-1 (ZO-1) at the tight junctions and alterations in F-actin cytoskeletal assembly. IL-1β treatment had no effect on ZO-1 gene (tjp1) or protein expression. Calpain inhibition via calpain inhibitor III and calpastatin decreased IL-1β-induced calpain activity significantly (p < 0.05). IL-1β had no detectable effect on intracellular calcium mobilization or endothelial cell viability. Furthermore, calpain inhibition preserved BBB integrity/permeability in a mouse controlled cortical impact model of TBI when studied using Evans blue assay and intravital microscopy. These studies demonstrate that calpain-1 acts as a mediator of IL-1β-induced loss of BBB integrity and permeability by altering tight junction integrity, promoting the displacement of ZO-1, and disorganization of cytoskeletal assembly. IL-1β-mediated alterations in permeability are neither due to the changes in ZO-1 expression nor cell viability. Calpain inhibition has beneficial effects against TBI-induced BBB hyperpermeability.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  calpain; inflammation; inhibitor; interleukin 1 (IL-1); vascular biology

Mesh:

Substances:

Year:  2016        PMID: 27875293      PMCID: PMC5207131          DOI: 10.1074/jbc.M116.735365

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Calpain cleavage of integrin beta cytoplasmic domains.

Authors:  M Pfaff; X Du; M H Ginsberg
Journal:  FEBS Lett       Date:  1999-10-22       Impact factor: 4.124

2.  Regulation of blood-brain barrier permeability.

Authors:  W G Mayhan
Journal:  Microcirculation       Date:  2001-04       Impact factor: 2.628

3.  Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study.

Authors:  A M Blamire; D C Anthony; B Rajagopalan; N R Sibson; V H Perry; P Styles
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

4.  Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.

Authors:  Tamiji Tsubokawa; Ihsan Solaroglu; Hiroshi Yatsushige; Julian Cahill; Kenichiro Yata; John H Zhang
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

5.  Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.

Authors:  Donald Wong; Katerina Dorovini-Zis; Steven R Vincent
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

Review 6.  Inflammatory mediators and modulation of blood-brain barrier permeability.

Authors:  N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 7.  Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors.

Authors:  Swapan K Ray; Edward L Hogan; Naren L Banik
Journal:  Brain Res Brain Res Rev       Date:  2003-05

Review 8.  The calpain system.

Authors:  Darrell E Goll; ValeryY F Thompson; Hongqi Li; Wei Wei; Jinyang Cong
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation.

Authors:  A Glading; R J Bodnar; I J Reynolds; H Shiraha; L Satish; D A Potter; H C Blair; A Wells
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Systemic administration of a calpain inhibitor reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat.

Authors:  A Germanò; C Costa; S M DeFord; F F Angileri; F Arcadi; B R Pike; P Bramanti; B Bausano; X Zhao; A L Day; D K Anderson; R L Hayes
Journal:  J Neurotrauma       Date:  2002-07       Impact factor: 5.269

View more
  11 in total

1.  Exploring blood-brain barrier hyperpermeability and potential biomarkers in traumatic brain injury.

Authors:  Bobby Darnell Robinson; Binu Tharakan; Angela Lomas; Katie Wiggins-Dohlvik; Himakarnika Alluri; Chinchusha Anasooya Shaji; Daniel Jupiter; Claire Larson Isbell
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-04-02

Review 2.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

3.  Distinct peripheral blood monocyte and neutrophil transcriptional programs following intracerebral hemorrhage and different etiologies of ischemic stroke.

Authors:  Paulina Carmona-Mora; Bradley P Ander; Glen C Jickling; Cheryl Dykstra-Aiello; Xinhua Zhan; Eva Ferino; Farah Hamade; Hajar Amini; Heather Hull; Frank R Sharp; Boryana Stamova
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-22       Impact factor: 6.200

Review 4.  Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets.

Authors:  Suraj Sulhan; Kristopher A Lyon; Lee A Shapiro; Jason H Huang
Journal:  J Neurosci Res       Date:  2018-09-27       Impact factor: 4.164

5.  Interleukin-10 attenuates impairment of the blood-brain barrier in a severe acute pancreatitis rat model.

Authors:  Ronggui Lin; Fei Chen; Shi Wen; Tianhong Teng; Yu Pan; Heguang Huang
Journal:  J Inflamm (Lond)       Date:  2018-02-27       Impact factor: 4.981

6.  The Degradation of Airway Epithelial Tight Junctions in Asthma Under High Airway Pressure Is Probably Mediated by Piezo-1.

Authors:  Jia Zhou; Xiang-Dong Zhou; Rui Xu; Xian-Zhi Du; Qi Li; Bin Li; Guo-Yue Zhang; Ling-Xiu Chen; Juliy M Perelman; Victor P Kolosov
Journal:  Front Physiol       Date:  2021-04-01       Impact factor: 4.566

7.  Extending the Calpain-Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma.

Authors:  Rachel C Knopp; Ammar Jastaniah; Oleksii Dubrovskyi; Irina Gaisina; Leon Tai; Gregory R J Thatcher
Journal:  ACS Pharmacol Transl Sci       Date:  2021-02-02

8.  The Tri-phasic Role of Hydrogen Peroxide in Blood-Brain Barrier Endothelial cells.

Authors:  Chinchusha Anasooya Shaji; Bobby D Robinson; Antonia Yeager; Madhava R Beeram; Matthew L Davis; Claire L Isbell; Jason H Huang; Binu Tharakan
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

Review 9.  Calpain proteolytic systems counteract endothelial cell adaptation to inflammatory environments.

Authors:  Takuro Miyazaki; Risako Akasu; Akira Miyazaki
Journal:  Inflamm Regen       Date:  2020-04-02

Review 10.  Mechanisms of Blood-Brain Barrier Dysfunction in Traumatic Brain Injury.

Authors:  Alison Cash; Michelle H Theus
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.